ArticleBio-protocol2026
Reconstitution of Active Plant H
Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Membrane transporters mediate the selective movement of ions and molecules across biological membranes and are essential for cellular homeostasis. However, their functional characterization in living cells is often complicated by the complexity of the native membrane environment. Reconstitution into model membrane systems provides a powerful alternative by enabling precise control over lipid composition and experimental conditions. Giant unilamellar vesicles (GUVs) are particularly well suited for transporter studies, as their cell-sized dimensions allow direct microscopic observation and fluorescence-based measurements of protein activity. Here, we describe a two-step reconstitution protocol in which transport proteins are first incorporated into large unilamellar vesicles and then used to generate protein-containing giant unilamellar vesicles (proteo-GUVs) via the poly(vinyl alcohol) swelling method. This two-step approach enhances protein incorporation efficiency and preserves transporter functionality. The method is exemplified using the P3-type ATPase
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.